Bespoke Extracts (BSPK) Assets Average (2011 - 2025)
Bespoke Extracts (BSPK) reported Assets Average of $281305.5 for Q3 2025, down 20.25% on a YoY basis from $352746.0 in Q3 2024, and up 9.21% sequentially from $257581.5 in Q2 2025.
Bespoke Extracts (BSPK) Assets Average (2011 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 15 years of Assets Average data on file, last reported at $281305.5 in Q3 2025.
- For the quarter ending Q3 2025, Assets Average fell 20.25% year-over-year to $281305.5; the trailing twelve-month figure through Sep 2025 stood at $281305.5 (down 20.25% YoY), and the FY2024 full-year result was $356724.0, down 6.61% from the prior year.
- Assets Average climbed to $281305.5 in Q3 2025, from $257581.5 in the prior quarter.
- In the past five years, Assets Average ranged from a high of $490883.5 in Q1 2021 to a low of $95813.0 in Q4 2021.
- A 5-year average of $355682.2 and a median of $361656.5 in 2024 frame the typical range for Assets Average.
- Peak annual rise in Assets Average reached 513.96% in 2021, while the deepest fall reached 61.79% in 2021.
- Tracing BSPK's Assets Average over 5 years: stood at $95813.0 in 2021, then surged by 306.64% to $389613.5 in 2022, then declined by 4.72% to $371234.5 in 2023, then decreased by 6.11% to $348551.5 in 2024, then dropped by 19.29% to $281305.5 in 2025.
- Business Quant data shows BSPK's Assets Average at $281305.5 in Q3 2025, $257581.5 in Q2 2025, and $303606.5 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 281,305.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 281,305.50 |
| Jun 30, 2025 | 257,581.50 |
| Mar 31, 2025 | 303,606.50 |
| Dec 31, 2024 | 348,551.50 |
| Sep 30, 2024 | 352,746.00 |
| Jun 30, 2024 | 361,656.50 |
| Mar 31, 2024 | 355,098.00 |
| Dec 31, 2023 | 371,234.50 |
| Sep 30, 2023 | 418,197.50 |
| Jun 30, 2023 | 463,397.50 |
| Mar 31, 2023 | 444,050.00 |
| Dec 31, 2022 | 389,613.50 |
| Sep 30, 2022 | 387,132.00 |
| Jun 30, 2022 | 463,589.00 |
| Mar 31, 2022 | 294,828.00 |
| Nov 30, 2021 | 95,813.00 |
| Aug 31, 2021 | 208,838.50 |
| May 31, 2021 | 469,838.50 |
| Feb 28, 2021 | 490,883.50 |
| Nov 30, 2020 | 250,747.50 |